Skip to main content

COVID-19 Research Resources
A curated list of research resources around guidelines, policies, and procedures related to COVID-1, drawn from Harvard University, affiliated academic healthcare centers, and government funding agencies

COVID-19 Research Resources
A curated list of research resources around guidelines, policies, and procedures related to COVID-1, drawn from Harvard University, affiliated academic healthcare centers, and government funding agencies

Calendar

Grand rounds: Addressing Vulnerability in Cluster Randomized Trials Involving People Living with Dementia in Nursing Homes – November 17

Thursday, November 17, 2022
12:00 pm – 1:00 pm
Zoom

Grand rounds: Addressing Vulnerability in Cluster Randomized Trials Involving People Living with Dementia in Nursing Homes

Charles Weijer, MD, PhD, will present. Weijer is a leading expert in the ethics of randomized controlled trials. From 2008 to 2013 he co-led a collaboration that produced the first international ethics guidelines for cluster randomized trials. His current work explores ethical issues in pragmatic randomized controlled trials that evaluate health interventions in real-world conditions to better inform patients, health providers, and health systems managers. He led the writing team for the World Health Organization guidance on “Ethical Considerations for Health Policy and Systems Research,” published in 2019. In 2020, he served on the WHO Working Group for Guidance on Human Challenge Studies in COVID-19. He is currently a member of the Peruvian National Academy of Medicine Committee on Clinical Trials in Lower- and Middle-Income Countries. Additionally, Weijer held the Canada Research Chair in Bioethics from 2005 to 2019, and, in 2016, he was elected to the Royal Society of Canada.

Sign up to receive our newsletter: courses, funding, events, and resources.